Aktis Oncology, Inc.
AKTS
$25.00
$0.281.13%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.93% | 137.44% | -- | ||
| Total Receivables | 4.55% | 100.00% | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 51.07% | 34.38% | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | -3.57% | 136.18% | -- | ||
|
|
|||||
| Total Current Assets | -3.57% | 136.18% | -- | ||
| Net Property, Plant & Equipment | 0.30% | 3.17% | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 2.34% | -35.19% | -- | ||
| Total Assets | -3.33% | 117.76% | -- | ||
|
|
|||||
| Total Accounts Payable | 106.44% | -29.36% | -- | ||
| Total Accrued Expenses | 71.13% | -33.86% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 3.36% | 8.75% | -- | ||
| Total Finance Division Other Current Liabilities | -8.54% | 1.59% | -- | ||
| Total Other Current Liabilities | -8.54% | 1.59% | -- | ||
| Total Current Liabilities | 15.10% | -10.64% | -- | ||
|
|
|||||
| Total Current Liabilities | 15.10% | -10.64% | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | -3.79% | -0.84% | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -5.41% | -9.74% | -- | ||
| Total Liabilities | 2.92% | -8.93% | -- | ||
|
|
|||||
| Common Stock & APIC | 0.50% | 6,467.42% | -- | ||
| Retained Earnings | -13.81% | -11.70% | -- | ||
| Treasury Stock & Other | -209.13% | -673.81% | -- | ||
| Total Common Equity | -4.20% | 446.30% | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
|
|
|||||
| Total Common Equity | -4.20% | 446.30% | -- | ||
| Total Preferred Equity | -- | -- | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | -4.20% | 170.27% | -- | ||
|
|
|||||